Gabriel Arefalk
Physician at Department of Medical Sciences; Clinical Epidemiology
- Telephone:
- +46 18 611 98 89
- Mobile phone:
- +46 73 985 26 50
- E-mail:
- Gabriel.Arefalk@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Publications
Recent publications
Part of Journal of the American Medical Association (JAMA), p. 1160-1169, 2025
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Part of NEJM evidence, 2024
Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
Part of Journal of the American Heart Association, 2024
- DOI for Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
- Download full text (pdf) of Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
Part of Contemporary Clinical Trials Communications, 2024
- DOI for Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
- Download full text (pdf) of Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
Part of American Heart Journal, p. 13-24, 2021
All publications
Articles in journal
Part of Journal of the American Medical Association (JAMA), p. 1160-1169, 2025
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Part of NEJM evidence, 2024
Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
Part of Journal of the American Heart Association, 2024
- DOI for Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
- Download full text (pdf) of Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
Part of Contemporary Clinical Trials Communications, 2024
- DOI for Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
- Download full text (pdf) of Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
Part of American Heart Journal, p. 13-24, 2021
Oxygen Therapy in Suspected Acute Myocardial Infarction
Part of New England Journal of Medicine, p. 1240-1249, 2017
Part of Circulation, 2015
Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction
Part of Circulation, p. 325-323, 2014
Smokeless Tobacco (Snus) and Risk of Heart Failure: Results from Two Swedish Cohorts
Part of European Journal of Cardiovascular Prevention & Rehabilitation, p. 1120-1127, 2012
Smokeless Tobacco (Snus) And Risk Of Heart Failure In Two Swedish Cohorts
Part of Journal of Hypertension, 2010